BCV
TXG icon

Banque Cantonale Vaudoise’s 10x Genomics TXG Stock Holding History

Banque Cantonale Vaudoise’s Portfolio TXG Stock Details TXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-8,404
Closed -$315K – 1064
2024
Q1 		$315K Sell
8,404
-3,359
-29% -$148K 0.01% 497
2023
Q4 		$658K Sell
11,763
-2,365
-17% -$103K 0.03% 405
2023
Q3 		$583K Sell
14,128
-181
-1% -$9.42K 0.03% 445
2023
Q2 		$799K Buy
+14,309
New +$774K 0.04% 395

Other funds holding TXG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Banque Cantonale Vaudoise's TXG Position: Q2 2024 in Review

Banque Cantonale Vaudoise sold out of 10x Genomics (TXG) in Q2 2024, closing a stake of 8,404 shares — an estimated $315K sold.

Banque Cantonale Vaudoise first reported a position in TXG in Q2 2023 and held it in 4 quarters. The position peaked at $799K in Q2 2023. 261 funds tracked by Wall St. Rank hold TXG as of Q2 2024.

  • Banque Cantonale Vaudoise reported no remaining 10x Genomics position as of Q2 2024 after selling out during the quarter.
  • Banque Cantonale Vaudoise sold 8,404 10x Genomics shares in Q2 2024, an estimated $315K.
  • Banque Cantonale Vaudoise first reported a position in 10x Genomics in Q2 2023 and held it in 4 quarters.
  • Banque Cantonale Vaudoise's 10x Genomics position peaked at $799K in Q2 2023.
  • 261 funds tracked by Wall St. Rank held 10x Genomics as of Q2 2024.

Based on Banque Cantonale Vaudoise's 13F filing for Q2 2024, filed 31 Jul 2024.